Pharmabiz

Is GLP–1 the new growth wave for Indian pharma as country battles diabetes and obesity cases?

Once viewed as a country predominantly burdened by undernutrition, India today carries one of the world’s largest populations living with diabetes and a rapidly expanding prevalence of overweight and ...
Pharmabiz

NunaBio secures £6.5 mn to scale next-generation DNA platform and advance infrastructure for synthetic biology

NunaBio secures £6.5 mn to scale next-generation DNA platform and advance infrastructure for synthetic biology: Newcastle, UK Wednesday, May 13, 2026, 18:00 Hrs [IST] NunaBio, a ...
Pharmabiz

GE HealthCare next-gen SIGNA MR tools and technology advance research discovery and translate innovation into clinical impact

GE HealthCare next-gen SIGNA MR tools and technology advance research discovery and translate innovation into clinical impact: Chicago Wednesday, May 13, 2026, 17:00 Hrs [IST] As ...
Pharmabiz

WFNS Innovation & Technology Committee with Time Medical, strengthens neurosurgical innovation

WFNS Innovation & Technology Committee with Time Medical, strengthens neurosurgical innovation: Our Bureau, Bengaluru Wednesday, May 13, 2026, 17:20 Hrs [IST] The World Federation ...
Pharmabiz

JDMEHF to hold healthcare & education outreach initiatives

Jassar Dental Medical Education Health Foundation (JDMEHF) has announced a series of community-focused initiatives in Modinagar and nearby regions in the lead-up to Founder’s Day on September 15, 2026 ...
Pharmabiz

BorderPlus launches B.R.I.D.G.E, national standardised exam for nurses seeking international careers

BorderPlus launches B.R.I.D.G.E, national standardised exam for nurses seeking international careers: Our Bureau, Bengaluru Wednesday, May 13, 2026, 14:40 Hrs [IST] BorderPlus, In ...
Pharmabiz

Lilly launches Lormalzi, first and only once-monthly amyloid plaque-targeting therapy to treat early symptomatic Alzheimer’s disease in India

Lilly launches Lormalzi, first and only once-monthly amyloid plaque-targeting therapy to treat early symptomatic Alzheimer’s disease in India: Our Bureau, Mumbai Wednesday, May ...
Pharmabiz

Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at ASCO 2026

Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at ASCO 2026: Rahway, New Jersey Wednesday, May 13, 2026, 11:00 Hrs [IST ...
Pharmabiz

Novo Nordisk’s higher dose Wegovy shows 28% weight loss in early responders according to new analyses

Novo Nordisk’s higher dose Wegovy shows 28% weight loss in early responders according to new analyses: Bagsværd, Denmark Wednesday, May 13, 2026, 16:00 Hrs [IST] Novo Nordisk, ...
Pharmabiz

Vyome strikes deal with Impetis Biosciences, opening a $57 billion market opportunity

Vyome strikes deal with Impetis Biosciences, opening a $57 billion market opportunity: Our Bureau, Bengaluru Wednesday, May 13, 2026, 14:30 Hrs [IST] Vyome Holdings, Inc. has inke ...
Pharmabiz

Abbott introduces Ensure Strength Pro in India to support healthy ageing

Abbott introduces Ensure Strength Pro in India to support healthy ageing: Our Bureau, Mumbai Wednesday, May 13, 2026, 14:50 Hrs [IST] Abbott, the global healthcare company, announ ...
Pharmabiz

Even Hospital partners with Canara Surgicals to improve minimally invasive surgeries’

Even Hospital, a Bengaluru-based multi-speciality hospital, has collaborated with surgical-tech firm Canara Surgicals to introduce the latter’s laser technology-based medical devices facilitating ...